Table 4 |
|||||||
|
Correlation coefficients and their significance for the four groups |
|||||||
| ER |
PR |
Ki-67 |
Tumor size |
Age |
p53 |
c-erbB-2 |
|
|
|
|||||||
| (V)DMSA 10 min |
|||||||
| r |
-0.24 |
-0.46 |
0.37 |
0.32 |
0.30 |
-0.06 |
-0.09 |
| P |
0.187 |
0.010 |
0.038 |
0.081 |
0.093 |
0.745 |
0.640 |
| (V)DMSA 60 min |
|||||||
| r |
-0.26 |
-0.51 |
0.42 |
0.25 |
0.22 |
0.23 |
0.09 |
| P |
0.157 |
0.003 |
0.018 |
0.178 |
0.226 |
0.206 |
0.617 |
| MIBI 10 min |
|||||||
| r |
-0.02 |
-0.25 |
0.23 |
0.29 |
0.19 |
0.33 |
-0.11 |
| P |
0.917 |
0.250 |
0.279 |
0.166 |
0.372 |
0.121 |
0.626 |
| MIBI 60 min |
|||||||
| r |
-0.01 |
-0.27 |
0.35 |
0.45 |
0.27 |
0.22 |
-0.04 |
| P |
0.953 |
0.211 |
0.097 |
0.027 |
0.202 |
0.305 |
0.848 |
|
|
|||||||
|
ER, estrogen receptor; MIBI, sestamibi; PR, progesterone receptor; (V)DMSA, pentavalent dimercaptosuccinic acid. |
|||||||
|
Papantoniou et al. Breast Cancer Res 2004 6:R56 |
|||||||